Study in Japan and Ex-Japan to Characterize the Pharmacokinetic and Pharmacodynamic Response to Orteronel (TAK-700) in Chemotherapy-Naïve Patients With Castration-Resistant Prostate Cancer
This study has been completed.
Millennium Pharmaceuticals, Inc.
First Posted: August 16, 2012
Last Update Posted: September 23, 2016
Information provided by (Responsible Party):
Takeda ( Millennium Pharmaceuticals, Inc. )
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study has been completed.|
|Study Completion Date:||November 2013|
|Primary Completion Date:||September 2013 (Final data collection date for primary outcome measure)|
|Certification or Request for Extension to Delay Results Submission:||March 28, 2016|